Zentalis Pharmaceuticals (ZNTL) Profit After Tax (2022 - 2025)
Historic Profit After Tax for Zentalis Pharmaceuticals (ZNTL) over the last 4 years, with Q3 2025 value amounting to -$26.7 million.
- Zentalis Pharmaceuticals' Profit After Tax rose 3353.5% to -$26.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$149.3 million, marking a year-over-year increase of 1672.56%. This contributed to the annual value of -$165.9 million for FY2024, which is 4325.55% up from last year.
- Latest data reveals that Zentalis Pharmaceuticals reported Profit After Tax of -$26.7 million as of Q3 2025, which was up 3353.5% from -$26.9 million recorded in Q2 2025.
- In the past 5 years, Zentalis Pharmaceuticals' Profit After Tax registered a high of $10.1 million during Q1 2024, and its lowest value of -$112.6 million during Q2 2023.
- Over the past 4 years, Zentalis Pharmaceuticals' median Profit After Tax value was -$55.0 million (recorded in 2022), while the average stood at -$53.1 million.
- In the last 5 years, Zentalis Pharmaceuticals' Profit After Tax soared by 11591.48% in 2024 and then plummeted by 57952.92% in 2025.
- Over the past 4 years, Zentalis Pharmaceuticals' Profit After Tax (Quarter) stood at -$55.0 million in 2022, then fell by 10.83% to -$60.9 million in 2023, then increased by 22.1% to -$47.5 million in 2024, then surged by 43.78% to -$26.7 million in 2025.
- Its Profit After Tax was -$26.7 million in Q3 2025, compared to -$26.9 million in Q2 2025 and -$48.3 million in Q1 2025.